Techne Corp
Article Abstract:
The shares of Techne Corp. have worthwhile price appreciation potential over the 2010-2012 timeframe. The Minneapolis, Minnesota-based company manufactures biotechnology products for research and clinical diagnostocs and blood analysis.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Drugs, Evaluation, Biotechnology industry, Biotechnology industries, Stocks, Stock prices, Techne Corp.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Medarex Inc
Article Abstract:
Medarex has cash but it would hardly be enough to cover rising research and development costs and the convertible notes that expire in 2006. Issue is untimely and only risk-tolerant investors should commit.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
United States, Sales, profits & dividends, Forecasts, trends, outlooks, Financial management, Labor Distribution by Employer, Finance, Company investment, Investments, Statistics, Vaccines industry, Biological products industry, Company sales and earnings, Company earnings/profit, Company business forecast/projection, Company forecasts, Medarex Inc., MEDX
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Securities, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.